We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Class of Drugs May Reduce Cardiovascular Risk by Targeting Gut Microbes

News   Aug 13, 2018 | Original story from Cleveland Clinic

 
New Class of Drugs May Reduce Cardiovascular Risk by Targeting Gut Microbes
 
 
 

RELATED ARTICLES

Obesity May be Predicted by Oral Bacteria in Young Children

News

The composition of oral microbiota, including beneficial bacteria, residing in the mouth of two-year-old children may predict their weight gain.

READ MORE

UK-India Project Combats Infections Threat with Diagnostics

News

A £3 million interdisciplinary research project is to address the growing threat of drug-resistant infections in India.

READ MORE

Engineered E. coli Adds Value in Chemical Production

News

An E. coli strain has been engineered that converts formic acid and CO2 to pyruvate and produces cellular energy from formic acid, providing a new platform for producing value-added chemicals from one-carbon sources.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE